Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Ai-Chen (Jane) Ho"'
Autor:
Michele Golino, Francesco Moroni, Marco Giuseppe Del Buono, Justin M. Canada, Azita H. Talasaz, Sebastian Piñel, James Mbualungu, Alessandra Vecchiè, Ai-Chen (Jane) Ho, Georgia K. Thomas, Salvatore Carbone, Hayley E. Billingsley, Jeremy Turlington, Roshanak Markley, Cory Trankle, Roberto De Ponti, Benjamin Van Tassell, Antonio Abbate
Publikováno v:
Cells, Vol 12, Iss 8, p 1129 (2023)
Background: Interleukin-1 blockade with anakinra leads to a transient increase in eosinophil blood count (eosinophils) in patients with acute myocardial infarction. We aimed to investigate the effect of anakinra on changes in eosinophils in patients
Externí odkaz:
https://doaj.org/article/aa0a313257b14981a86d62e56d30cc87
Autor:
Virginia Mihalick, George Wohlford, Azita H. Talasaz, Ai-Chen (Jane) Ho, Francine Kim, Justin M. Canada, Salvatore Carbone, Dinesh Kadariya, Hayley Billingsley, Cory Trankle, Marco Giuseppe Del Buono, Francesco Moroni, Ross Arena, Antonio Abbate, Benjamin Van Tassell
Publikováno v:
Am J Cardiol
Interleukin-1 (IL-1) blockade is an anti-inflammatory treatment that may affect exercise capacity in heart failure (HF). We evaluated patient-reported perceptions of exertion and dyspnea at submaximal exercise during cardiopulmonary exercise testing
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b69327fdb0099d9f7148ad10f2efe933
https://europepmc.org/articles/PMC9426769/
https://europepmc.org/articles/PMC9426769/
Autor:
Azita Hajhossein Talasaz, Dave L. Dixon, Fawzia Bhatty, Rachel A. Koenig, Benjamin W. Van Tassell, William L. Baker, Ai-Chen Jane Ho
Publikováno v:
PharmacotherapyREFERENCES. 41(12)
The advent of monoclonal antibodies targeting proprotein convertase subtilisin/kexin type 9 (PCSK9) ushered in a new era of dyslipidemia pharmacotherapy. The first two antibodies targeting PCSK9 (evolocumab, alirocumab) approved by the United States